WEST NILE VIRUS
This presentation is the property of its rightful owner.
Sponsored Links
1 / 41

WEST NILE VIRUS PowerPoint PPT Presentation


  • 63 Views
  • Uploaded on
  • Presentation posted in: General

WEST NILE VIRUS. West Nile Virus: Background. First isolated 1937 Flavivirus Africa, West Asia, Europe and the Middle East 1999 US isolate similar to a goose isolate from Israel. Mosquito vector. Incidental infections. Incidental infections. Bird reservoir hosts.

Download Presentation

WEST NILE VIRUS

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


West nile virus

WEST NILE VIRUS


West nile virus background

West Nile Virus: Background

  • First isolated 1937

  • Flavivirus

  • Africa, West Asia, Europe and the Middle East

  • 1999 US isolate similar to a goose isolate from Israel


West nile virus

Mosquito vector

Incidental infections

Incidental infections

Bird

reservoir hosts

Incubation period -- 3 to 15 days


West nile virus

Vectors and Hosts

  • Isolated from over 43 mosquito species

    • Mostly Culex species:

      • Cx. univittatus, Cx. perixiguus, Cx. pipiens, Cx. modestus, Cx. quinquefasciatus, Cx. tritaeniorhynchus, and Cx. vishnui

    • Other mosquito species:

      • Aedes, Aedeomyia, Anopheles,

      • Coquillettidia, Mansonia, Mimomyia


Culex tarsalis

Culex tarsalis

Majorvector potential WNV vector in Western US


Epidemiology

Epidemiology

  • Mosquitoes feed on infected birds

  • Pass the virus to warm-blooded animals.

  • Horses cannot spread WNV to other horses, people or pets.

    Dead-end Host


Mammals

Mammals

  • Infected with WN virus

    • Mortality: bats, rabbit, chipmunk, gray squirrel, horse, cat, alpaca, dog

    • Seropositive: dog, bears, sheep, goats, wolf


Clinical signs

Clinical Signs

  • Ataxia 86%

  • Depression 51%

  • Hindlimb weakness 49%

  • Difficulty or inability to rise 46%

  • Muscle tremors 41%

  • Fever only 24%

  • Death in 25-33% of affected horses


Clinical signs colorado

Clinical Signs: Colorado

  • Clinical signs:

    • Ataxia – 73%

    • Weakness – 69%

    • Lethargy, depression – 61%

    • Muscle fasciculations – 60%

    • Unable to rise on their own – 38%***

    • Fever – 35%

    • Altered mentation – 31%

    • Hypersesthesia – 30%

    • Cranial nerve deficits – 27%


Subclinical infection

Subclinical Infection

  • Symptomatic:asymptomatic ratio is approximately 1:9


Epidemiology colorado

Epidemiology: Colorado

  • 9 years (3 mos – 35 yrs)

  • No breed, gender predilection

  • 71.4% (344/482) survived

  • Horses that died were older

  • Unvax: 36.6% mortality

  • At least one vax: 20.3% mortality


Recumbent horses

Recumbent Horses

  • Average duration: 2.3 days

  • Range: 1-7 days

  • Onset to recumbency: 2.1 days (range = 0-14 days)

  • Recumbency as first sign: 4 horses

  • Nonvax 2.4 times more likely to be unable to rise


Diagnosis

Diagnosis

  • Clinical signs

  • CSF: mononuclear pleocytosis, normal to increased protein

  • IgM antigen-capture ELISA

  • Plaque reduction neutralization assay

  • PCR, IHC


Diagnosis1

Diagnosis

  • Serum and CSF results similar

  • Horses do not develop an IgM response to vaccine


Treatment

Treatment

  • Symptomatic

  • IV fluids

  • Anti-inflammatory medication

    • Flunixin meglumine

    • DMSO

    • Corticosteroids


Treatment of wnv

Treatment of WNV

  • Alpha interferon

  • Hyperimmune plasma


Prognosis colorado

Prognosis: Colorado

  • 82% considered fully recovered

  • Some residual signs in 21% (decreased stamina, weight loss)

  • Estimated 2 unreported cases for every 3 laboratory confirmed cases


Increased likelihood of survival if

Increased likelihood of survival if:

  • Steroid treatment (p=0.10)

  • Hospitalization (p<0.0001)

  • Vaccination (p=0.0005)

  • Not recumbent

  • Affected late in epidemic


Aged horses 18 yrs

Aged Horses (>18 yrs)

  • Survivors avg. age = 8.9 yrs

  • Nonsurvivors avg. age = 10.8 yrs

  • Aged were 2.6 times as likely to die

  • Older horses not more likely to be recumbent

  • Older horses not less likely to be vaccinated


Treatment of wnv1

Treatment of WNV

  • Anti-inflammatory medication

    • Flunixin meglumine

    • DMSO

    • Corticosteroids?


Residual effects

Residual Effects

  • Florida: 15%

  • Minnesota: 40%

    • Average followup time 6 months

    • 59.2% had no neurologic or behavioral abnormalities

    • Average duration of signs: 35 days (1-180)


Residual effects1

Residual Effects

  • Behavioral change

  • Loss of muscle mass

  • More frequent stumbling

  • Diminished energy

  • Weak hind limbs

  • “Abnormal” gait

  • Vision loss

  • Dysphagia

  • Relapses (2 wk to 5 mo)


Prevention of wnv

Prevention of WNV

  • Eliminate mosquito breeding sites

  • Control mosquito larvae

  • Reduce exposure to adult mosquitoes

  • Vaccinate


West nile virus

Mosquito Breeding Sites

1. Storm drains

2. Clogged roof gutters

3. Window wells

4. Uncovered containers

5. Leaky faucets and standing water

6. Garden ponds

7. Swimming pools

8. Tires and wheelbarrows

9. Birdbaths and children’s toys


Control mosquito larvae

Control Mosquito Larvae

  • Stock water tanks with fish that consume mosquito larvae

  • Use mosquito “dunks” in water tanks

  • Clean water tanks weekly


Reduce exposure to adult mosquitoes

Reduce Exposure to Adult Mosquitoes

  • Stable horses during active mosquito feeding times

  • Screen the stables

  • Fans, barrier cloth, flysheets

  • Repellants applied frequently


Wnv vaccine whole virus

WNV Vaccine-whole virus

  • 1cc dose, booster 3-6 weeks

  • Induces antibody response

  • Conditional license


Does the vaccine work

Infect Horse Experimentally

Vaccinate Horse

See if horse gets disease

Does the Vaccine Work?

The BEST way to test a vaccine: Experimental Challenge Model

Most horses do not get sick after experimental infection!


Vaccine efficacy

Vaccine Efficacy

Experimental Challenge

  • One year after vaccination

  • Controls

    • 9 of 11 infected--82%

  • Vaccinates

    • 1 of 19 infected--5% (95% Protective)


Infection mortality vs vaccine status colorado

Infection & Mortality vs. Vaccine Status:Colorado

372 Total

230 = No Vax

97 = 1 Vax

45 = 2 Vax


California cases 2004

California Cases - 2004


Post approval reaction rates fort dodge

Post-Approval Reaction Rates:Fort Dodge

  • <0.025% adverse effects reported

  • lumps and bumps

  • fever

  • lack of efficacy ?


West nile virus

http://lost-foals-group.4t.com/


Merial vaccine

Merial Vaccine

  • Canarypox vector

  • Mosquito challenge model

  • Similar results for safety, efficacy


Web site resources

Web site resources

For more information about humans and WNV: www.cdc.gov

For more information about WNV, USDA Website: www.aphis.usda.gov/oa/wnv

For more information about WNV in horses:

http://prevmed.vet.ohio-state.edu/


  • Login